• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何计算输注的CD34+细胞数量?一项基于实际、理想或调整后的理想体重的单中心队列研究。

How to calculate the quantity of CD34+ cells infused? A single center cohort study based on actual, ideal or adjusted ideal body weight.

作者信息

Topcuoglu Pervin, Akcaglayan Soydan Ender, Ekiz Fuat, Ayyildiz Erol, Dalva Klara, Ozcan Muhit, Arslan Onder, Arat Mutlu, Ilhan Osman

机构信息

Ankara University, Faculty of Medicine, Department of Hematology, Hemapheresis and Blood Bank, Cebeci Kampüsü, 06590 Dikimevi, Ankara, Turkey.

出版信息

Transfus Apher Sci. 2007 Jun;36(3):275-80. doi: 10.1016/j.transci.2007.03.007. Epub 2007 Jun 13.

DOI:10.1016/j.transci.2007.03.007
PMID:17569588
Abstract

Transplant physicians are generally using the recipient's actual body weight (ABW) for the calculation of the content of CD34+ cells in the harvest material in hematopoietic stem cell transplantation (HSCT). As a reference center performing both the stem cell collection and HSCTs, we aimed to evaluate whether there were any differences for neutrophil recovery by calculating the CD34+ cell content in the graft according to actual, ideal (IBW) or adjusted IBW (AIBW) of the recipients in both autologous (n=148) and allogeneic stem cell collection setting (n=234). We observed a negative correlation between the neutrophil recovery and the cell doses infused as to each of these BWs in the allo-HSCT group, but not in the auto-HSCT group. This negative correlation was stronger for IBW and AIBW rather than for ABW in allo-HSCT group. In addition, calculations for both IBW and AIBW in autologous and allogeneic transplants revealed a significant difference in comparison to ABW for different cut-off values of infused CD34+ cells. Consequently, we suggested that both IBW and AIBW based calculations of CD34+ cells infused are better predictors of neutrophil recovery in comparison to ABW in allo-HSCT. We were not able to show this impact in autologous transplants.

摘要

在造血干细胞移植(HSCT)中,移植医生通常使用受者的实际体重(ABW)来计算采集材料中CD34+细胞的含量。作为一个同时进行干细胞采集和HSCT的参考中心,我们旨在评估在自体(n = 148)和异基因干细胞采集组(n = 234)中,根据受者的实际体重、理想体重(IBW)或调整后的理想体重(AIBW)计算移植物中CD34+细胞含量时,中性粒细胞恢复是否存在差异。在异基因HSCT组中,我们观察到中性粒细胞恢复与根据这些体重中的每一种所输注的细胞剂量之间呈负相关,但在自体HSCT组中未观察到这种相关性。在异基因HSCT组中,这种负相关性在IBW和AIBW时比在ABW时更强。此外,在自体和异基因移植中,针对IBW和AIBW的计算显示,与ABW相比,对于不同的输注CD34+细胞临界值存在显著差异。因此,我们认为,与ABW相比,在异基因HSCT中,基于IBW和AIBW计算输注的CD34+细胞是中性粒细胞恢复的更好预测指标。在自体移植中,我们未能显示出这种影响。

相似文献

1
How to calculate the quantity of CD34+ cells infused? A single center cohort study based on actual, ideal or adjusted ideal body weight.如何计算输注的CD34+细胞数量?一项基于实际、理想或调整后的理想体重的单中心队列研究。
Transfus Apher Sci. 2007 Jun;36(3):275-80. doi: 10.1016/j.transci.2007.03.007. Epub 2007 Jun 13.
2
Ideal or actual body weight to calculate CD34+ cell doses for allogeneic hematopoietic stem cell transplantation?计算异基因造血干细胞移植中CD34+细胞剂量时应采用理想体重还是实际体重?
Bone Marrow Transplant. 2004 Jan;33(2):161-4. doi: 10.1038/sj.bmt.1704388.
3
Ideal or actual body weight to calculate CD34+ cell doses for autologous hematopoietic stem cell transplantation?计算自体造血干细胞移植的CD34+细胞剂量时,使用理想体重还是实际体重?
Bone Marrow Transplant. 2003 May;31(10):861-4. doi: 10.1038/sj.bmt.1703955.
4
Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation.在异基因造血干细胞移植中,应使用理想体重而非实际体重来计算细胞剂量。
Bone Marrow Transplant. 2006 Mar;37(6):553-7. doi: 10.1038/sj.bmt.1705282.
5
Ideal body weight correlates better with engraftment after PBSC autograft than actual body weight, but is under-estimated in myeloma patients possibly due to disease-related height loss.与实际体重相比,理想体重与自体 PBSC 移植后的植入相关性更好,但骨髓瘤患者的理想体重可能因疾病相关的身高降低而被低估。
Bone Marrow Transplant. 2007 Oct;40(7):665-9. doi: 10.1038/sj.bmt.1705789. Epub 2007 Jul 23.
6
Comparison of autologous peripheral blood stem cell dosing by ideal vs actual body weight.理想体重与实际体重用于自体外周血干细胞给药的比较。
Bone Marrow Transplant. 1999 May;23(9):867-73. doi: 10.1038/sj.bmt.1701731.
7
The use of adjusted ideal body weight for overweight patients undergoing HPC mobilisation for autologous transplantation.超重患者行 HPC 动员行自体移植时使用调整后的理想体重。
Ann Hematol. 2012 Nov;91(11):1795-801. doi: 10.1007/s00277-012-1523-1. Epub 2012 Jul 27.
8
Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.在非霍奇金淋巴瘤自体干细胞移植后,较高的输注CD34+造血干细胞剂量与更早的淋巴细胞恢复及更好的临床结局相关。
Transfusion. 2009 Sep;49(9):1890-900. doi: 10.1111/j.1537-2995.2009.02202.x. Epub 2009 May 11.
9
Assessment of hematologic progenitor engraftment by complete reticulocyte maturation parameters after autologous and allogeneic hematopoietic stem cell transplantation.自体和异基因造血干细胞移植后通过完全网织红细胞成熟参数评估造血祖细胞植入情况。
Haematologica. 2001 Jan;86(1):24-9.
10
Intravenous busulfan in adults prior to haematopoietic stem cell transplantation: a population pharmacokinetic study.造血干细胞移植前成人静脉注射白消安的群体药代动力学研究。
Cancer Chemother Pharmacol. 2006 Jan;57(2):191-8. doi: 10.1007/s00280-005-0029-0. Epub 2005 Aug 25.